0001578563-17-000007.txt : 20170516 0001578563-17-000007.hdr.sgml : 20170516 20170516164310 ACCESSION NUMBER: 0001578563-17-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170516 DATE AS OF CHANGE: 20170516 EFFECTIVENESS DATE: 20170516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AYTU BIOSCIENCE, INC CENTRAL INDEX KEY: 0001385818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 470883144 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-286874 FILM NUMBER: 17849195 BUSINESS ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 200 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: (720) 437-6580 MAIL ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 200 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC. DATE OF NAME CHANGE: 20150609 FORMER COMPANY: FORMER CONFORMED NAME: Rosewind CORP DATE OF NAME CHANGE: 20070110 D 1 primary_doc.xml X0707 D LIVE 0001385818 AYTU BIOSCIENCE, INC 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO COLORADO 80112 (720) 437-6580 DELAWARE AYTU BIOSCIENCE, INC. Rosewind CORP Corporation true 2015 Joshua R. Disbrow c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Director Jarrett T. Disbrow c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Gregory A. Gould c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Michael Macaluso c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Carl C. Dockery c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director John A. Donofrio, Jr. c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Gary V. Cantrell c/o Aytu BioScience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Pharmaceuticals Decline to Disclose 06b false 2017-05-05 false true true Pursuant to a Merger Agreement, the Issuer issued 2,500,000 shares of common stock to certain stockholders of Nuelle, Inc., a Delaware corporation, pursuant to the terms and conditions of the merger. 0 Indefinite 1750000 Indefinite The total offering amount may be up to a maximum of $6,925,000 in earnout payments and up to a maximum of $24,000,000 in milestone payments under the Merger Agreement. false 16 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false AYTU BIOSCIENCE, INC /s/ Joshua Disbrow Joshua Disbrow Chief Executive Officer 2017-05-12